Catalyst Wire Dossier Catalyst Wire Dossier

Otelixizumab

otelixizumab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Otelixizumab, covering 2017-06-01 to 2019-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients [Phase 1, Phase 2]

See pricing